Rick Barnette

About Rick Barnette

As VP of Clinical Development and Therapeutic Strategy at Syneos Health, I support Phase 1–4 Hematology strategy development with a focus on non-malignant hematology, rare hematologic diseases, and emerging therapies. With more than 25 years of experience across clinical development, oncology, and CRO leadership, my work centers on helping advance innovative therapies for patients with unmet medical needs.Throughout my career, I’ve partnered with teams and sponsors to shape strategy, strengthen operational delivery models, and guide therapeutic area portfolios from concept to execution. I value building strong, trusting relationships and navigating cultural and geographic differences to ensure programs run smoothly and effectively. I take pride in creating an environment where teams feel supported and empowered to deliver meaningful results for patients and partners alike.

Experience

1. Vice President, Clinical Development- Therapeutic Strategy

   Syneos Health

   Jun 2021 — Present

Education

• Lorain County Community College

  Radiology

• University of North Carolina Wilmington

  Biology, General

Skills

• Pharmaceutical Industry
• Sop
• Cardiology
• Inform
• Data Management
• Ich-Gcp
• Patient Recruitment
• Crf Design
• Clinical Data Management
• Clinical Monitoring
• Regulatory Submissions
• Oracle Clinical
• Clinical Trials
• Good Clinical Practice (Gcp)
• Biotechnology
• CRO
• Medical Writing
• Clinical Development
• Oncology
• Protocol
• Regulatory Affairs
• Lifesciences
• Vaccines
• Edc
• Therapeutic Areas
• Ctms
• Hematology
• Clinical Operations
• Project Management
• Clinical Research
• Cancer
• Gcp
• Infectious Diseases
• Diabetes
• Pharmacovigilance